Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT…

Overview of attention for article published in Annals of Hematology, June 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,627 followers.

RT @Hema_News: Fludarabine & Rituximab w/ Escalating Doses of Lenalidomide followed by Lenalidomide/Rituximab Maintenance in Previously Unt…

09 Jun 2018

Reply Repost Favourite

Fludarabine & Rituximab w/ Escalating Doses of Lenalidomide followed by Lenalidomide/Rituximab Maintenance in Previously Untreated Chronic Lymphocytic Leukaemia (CLL): The REVLIRIT CLL-5 AGMT Phase I/II Study https://t.co/65WwRS8eXI

09 Jun 2018

Reply Repost Favourite